{
    "id": "643ff48a57b1c7a31500003d",
    "question": "Is omaveloxolone a suppressor of Nrf2?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine if omaveloxolone is a suppressor of Nrf2, we need to analyze the provided documents. Nrf2 is a transcription factor that regulates the expression of antioxidant proteins, and its activation is associated with the induction of antioxidant defenses. A suppressor of Nrf2 would likely inhibit its activity or expression. Omaveloxolone is an immunosuppressive drug, but its mechanism of action is not explicitly mentioned in the provided documents. However, we can look for connections between omaveloxolone and Nrf2 regulation. One potential connection is that some immunosuppressive drugs can have antioxidant effects, which might be mediated by Nrf2. Another connection is that Nrf2 is also involved in the regulation of metabolism, and some drugs can affect metabolic pathways that influence Nrf2 activity. Given the lack of direct information about omaveloxolone and Nrf2, we need to rely on general knowledge about the relationship between immunosuppressants and Nrf2. In general, immunosuppressants can have complex effects on metabolism and oxidative stress, and it is possible that omaveloxolone could influence Nrf2 activity. However, without direct evidence, it is difficult to conclude that omaveloxolone is a suppressor of Nrf2. Therefore, the answer cannot be definitively determined from the provided documents.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_4434",
            "title": "InternalMed_Harrison",
            "content": "pathway. If O2 becomes limiting, this critical hydroxylation step does not occur, allowing HIF-1\u03b1 to partner with other proteins, translocate to the nucleus, and upregulate the expression of the EPO gene, among others."
        },
        {
            "id": "Obstentrics_Williams_688",
            "title": "Obstentrics_Williams",
            "content": "Cervar M, Blaschitz A, Dohr G, et al: Paracrine regulation of distinct trophoblast functions in vitro by placental macrophages. Cell Tissue Res 295:297, 1999 Chennazhi, Nayak NR: Regulation of angiogenesis in the primate endometrium: vascular endothelial growth factor. Semin Reprod Med 27(1):80, 2009 Chigusa Y, Kishore AH, Mogami H, et al: Nrf2 activation inhibits efects of thrombin in human amnion cells and thrombin-induced preterm birth in mice. J Clin Endocrinol Metab 101(6):2612,r2016 Cock TA, Auwerx]: Leptin: cL1Cting the fat off the bone. Lancet 362: 1572, 2003 Cole A: Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chen 43:2233, 1997 Conneely OM, Mulac-]ericevic B, DeMayo F, et al: Reproductive functions of progesterone receptors. Recent Prog Horm Res 57:339, 2002"
        },
        {
            "id": "InternalMed_Harrison_5565",
            "title": "InternalMed_Harrison",
            "content": "have been explored in many experimental models. These include the nutrient-sensing pathways (TOR, AMPK, insulin/IGF-I, sirtuins) and transcription factors (FOXO in D. melanogaster and daf16 in C. elegans). The transcription factor Nrf2 appears to confer most of the anticancer properties of caloric restriction in mice, even though it is dispensable for lifespan extension."
        },
        {
            "id": "Pharmacology_Katzung_6138",
            "title": "Pharmacology_Katzung",
            "content": "Three other FDA-approved immunomodulators are used exclusively in the treatment of relapsing-remitting multiple sclerosis. Dimethyl fumarate (DMF) is the methyl ester of fumaric acid. Its exact mechanism of action is unknown, but it appears to activate the nuclear factor (erythroid-derived 2)-like 2 (NRF-2) transcriptional pathway. Activation of the NRF-2 pathway results in reduction of the oxidative stress that contributes to demyelination; it also appears to help protect the nerve cells from inflammation. DMF is given orally. Lymphopenia may be significant, so blood counts must be monitored regularly and the drug may be withheld if active infection is present. Flushing is common with treatment initiation and usually improves with time. Other less common adverse effects include nausea, diarrhea, abdominal pain, increased hepatic enzymes, and eosinophilia."
        },
        {
            "id": "InternalMed_Harrison_31000",
            "title": "InternalMed_Harrison",
            "content": "Dimethyl Fumarate (DMF) Although the precise mechanisms of action of DMF are not fully understood, it seems to have anti-inflammatory effects through its modulation of the expression of proinflammatory and anti-inflammatory cytokines. Also, DMF inhibits the ubiquitylation and degradation of nuclear factor E2-related factor 2 (Nrf2)\u2014a transcription factor that binds to the antioxidant response elements (AREs) located on the DNA and thereby induces the transcription of several antioxidant proteins. DMF reduces the attack rate and significantly improves all measures of disease severity in MS patients. However, its twice-daily oral dosing schedule makes it somewhat less convenient for patients than daily oral therapies. In addition, compliance is likely to be less with a twice-daily dosing regimen\u2014a factor that could be of concern given the observation (in a small clinical trial) that once-daily DMF lacks efficacy. A head-to-head trial provided evidence that DMF was superior to glatiramer"
        },
        {
            "id": "InternalMed_Harrison_5580",
            "title": "InternalMed_Harrison",
            "content": "Metformin. Metformin, an activator of AMPK, is a biguanide first isolated from the French lilac that is widely used for the treatment of type 2 diabetes mellitus. Metformin decreases hepatic gluconeogenesis and increases insulin sensitivity. Metformin has other actions including inhibition of mTOR and mitochondrial complex I and activation of the transcription factor SKN-1/Nrf2. Metformin increases lifespan in different mouse strains including female mouse strains predisposed to high incidence of mammary tumors. At a biochemical level, metformin supplementation is associated with reduced oxidative damage and inflammation and mimics some of the gene expression changes seen with caloric restriction."
        },
        {
            "id": "InternalMed_Harrison_5556",
            "title": "InternalMed_Harrison",
            "content": "SIRT1. The sirtuins are a class of histone deacetylases that inhibit gene expression. The key nutrient-sensing member of this class in mammals is SIRT1. The activity of SIRT1 is regulated by levels of reduced nicotinamide adenine dinucleotide (NAD+), which are increased when cellular energy stores are depleted. Important downstream targets include PGC1a and NRF2, which act on mitochondrial biogenesis. Target of rapamycin (TOR, or mTOR in mammals). mTOR is activated by branched-chain amino acids, providing a link to dietary protein intake. It is a complex that orchestrates two pathways (TORC1 and TORC2). Key downstream targets of mTOR of relevance to aging include the tuberous sclerosis protein (TSC) and 4EBP1, which influence protein production. 5\u2032 Adenosine monophosphate\u2013activated protein kinase (AMPK). AMPK is activated by increased levels of AMP, which reflect cellular energy status."
        },
        {
            "id": "Pathology_Robbins_1204",
            "title": "Pathology_Robbins",
            "content": "Deletions are another prevalent abnormality in tumor cells. Deletion of specific regions of chromosomes may result in the loss of particular tumor suppressor genes. Tumor suppressors generally require inactivation of both alleles in order for them to contribute to carcinogenesis. A common mechanism for this is an inactivating point mutation in one allele, followed by deletion of the other, non-mutated allele. As discussed later, deletions involving 13q14, the site of the RB gene, are associated with retinoblastoma, and deletion of 17p is associated with loss of TP53, arguably the most important tumor suppressor gene. http://ebooksmedicine.net"
        },
        {
            "id": "Physiology_Levy_1422",
            "title": "Physiology_Levy",
            "content": "12.21. Basic molecular signaling pathways involved in contributing to net protein synthesis (A) and mitochondrial biogenesis (B) in skeletal muscle in response to exercise. AKT, a serine/threonine-specific protein kinase (protein kinase B); AMPK, 5\u2032 adenosine monophosphate\u2013activated protein kinase; ATP, adenosine triphosphate; CaM kinase, Ca++/calmodulin-dependent protein kinase; CREB, cAMP response element binding protein; ERR\u03b1, estrogen-related receptor-\u03b1; FoxO, forkhead box O class of transcription factors; FoxO-P, phosphorylated FoxO; Glut-4, glucose transporter type 4; HDAC5, histone deacetylase 5; IGF-1, insulin-like growth factor 1; MEF2, myocyte enhancer factor 2; mTOR, mammalian target of rapamycin; Nrf1, Nrf2, and Nrf2\u03b1, nuclear respiratory factors 1, 2, and 2\u03b1; PGC-1\u03b1, peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1; PI3K, phosphatidylinositol-3-kinase; Tn I, troponin I. (A, From Sandri M, et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing Fo"
        },
        {
            "id": "Immunology_Janeway_1650",
            "title": "Immunology_Janeway",
            "content": "A. ___ Kit B. ___ B-cell receptor C. ___ fLT3 D. ___ TGf-\u03b2 receptor 7.3 Short Answer: how can scaffolds and adaptors modulate signaling responses if they have no intrinsic enzymatic activity? 7.4 Multiple Choice: Which of the following alterations would result in increased activity of Ras (one or more may apply): A. a mutation in Ras that enhances its GTpase activity B. overexpression of Gefs C. depletion of GTp in the cytoplasm D. overexpression of Gaps"
        },
        {
            "id": "Pathology_Robbins_1245",
            "title": "Pathology_Robbins",
            "content": "Isaac Newton theorized that every action has an equal and opposite reaction. Although Newton was not a cancer biologist, his formulation holds true for cell growth. Whereas oncogenes encode proteins that promote cell growth, the products of tumor suppressor genes apply brakes to cell proliferation. Disruption of such genes renders cells refractory to growth inhibition and mimics the growth-promoting effects of oncogenes. The following discussion describes tumor suppressor genes, their products, and possible mechanisms by which loss of their function contributes to unregulated cell growth."
        },
        {
            "id": "Pharmacology_Katzung_4356",
            "title": "Pharmacology_Katzung",
            "content": "region of the gene, and regulate transcription by RNA polymerase II and associated transcription factors. A variety of regulatory factors (not shown) may participate in facilitating (coactivators) or inhibiting (corepressors) the steroid response. The resulting mRNA is edited and exported to the cytoplasm for the production of protein that brings about the final hormone response. An alternative to the steroid-receptor complex interaction with a GRE is an interaction with and altering the function of other transcription factors, such as NF-\u03baB in the nucleus of cells."
        },
        {
            "id": "Surgery_Schwartz_268",
            "title": "Surgery_Schwartz",
            "content": "influence the functionality of target proteins.108 ROS can also contribute to transcriptional activity both indirectly through its effects on transcription factor lifespan, and directly through the oxidation of DNA.The role for ROS has been well described in phagocytes, which utilize these small molecules for pathogen killing. A sec-ond important role for ROS is in the regulation of the inflamma-some. As discussed previously, the inflammasome mediates the activation of inflammatory capsases leading to the production and secretion of mature cytokines in macrophages.109 Impor-tantly, the best described inflammasome, NLRP3, is redox sen-sitive. Increased intracellular ROS enables the assembly of the protein complex.110 ROS also appears to be involved in adap-tive immunity by influencing immune cell response.106 ROS can alter thiol group oxidative states on the cell surface and, in turn, affect cell signaling. Moreover, intracellular ROS can inhibit DNA transcription. ROS has been"
        },
        {
            "id": "Cell_Biology_Alberts_2352",
            "title": "Cell_Biology_Alberts",
            "content": "COMPLEMENTATION: MUTATIONS IN TWO DIFFERENT GENES DELETION: deletes a segment of a chromosome TRANSLOCATION: breaks off a segment from one chromosome and attaches it to another gain-of-function mutation: increases the activity of the gene or makes it active in inappropriate circumstances; these mutations are usually dominant. dominant-negative mutation: dominant-acting mutation that blocks gene activity, causing a loss-of-function phenotype even in the presence of a normal copy of the gene. This phenomenon occurs when the mutant gene product interferes with the function of the normal gene product. suppressor mutation: suppresses the phenotypic effect of another mutation, so that the double mutant seems normal. An intragenic suppressor mutation lies within the gene affected by the frst mutation; an extragenic suppressor mutation lies in a second gene\u2014often one whose product interacts directly with the product of the frst."
        },
        {
            "id": "InternalMed_Harrison_6024",
            "title": "InternalMed_Harrison",
            "content": "through their ability to control cell division (cell birth) or cell death (apoptosis), although the mechanisms can be extremely complex. While tightly regulated in normal cells, oncogenes acquire mutations in cancer cells, and the mutations typically relieve this control and lead to increased activity of the gene products. This mutational event typically occurs in a single allele of the oncogene and acts in a dominant fashion. In contrast, the normal function of tumor-suppressor genes is usually to restrain cell growth, and this function is lost in cancer. Because of the diploid nature of mammalian cells, both alleles must be inactivated for a cell to completely lose the function of a tumor-suppressor gene, leading to a recessive mechanism at the cellular level. From these ideas and studies on the inherited form of retinoblastoma, Knudson and others formulated the two-hit hypothesis, which in its modern version states that both copies of a tumor-suppressor gene must be inactivated in"
        },
        {
            "id": "Pathology_Robbins_4978",
            "title": "Pathology_Robbins",
            "content": "Acquiredmyopathieshavediversecauses,includinginflammationandtoxicexposures. http://ebooksmedicine.net A number of different tumors arise from peripheral nerves. Such tumors may manifest as soft tissue masses, with pain or loss of function related to impingement on nerves or other surrounding structures. In most peripheral nerve tumors, the neoplastic cells show evidence of Schwann cell differentiation. These tumors usually occur in adults and include both benign and malignant variants. An important feature is their frequent association with the familial tumor syndromes neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2)."
        },
        {
            "id": "Cell_Biology_Alberts_4394",
            "title": "Cell_Biology_Alberts",
            "content": "of its target genes. NF\u03baB also activates the transcription of the gene that encodes I\u03baB\u03b1, creating a negative feedback loop, which can produce prolonged oscillations in NF\u03baB activity with sustained extracellular signaling."
        },
        {
            "id": "Cell_Biology_Alberts_4362",
            "title": "Cell_Biology_Alberts",
            "content": "There are five NF\u03baB proteins in mammals (RelA, RelB, c-Rel, NF\u03baB1, and NF\u03baB2), and they form a variety of homodimers and heterodimers, each of which activates its own characteristic set of genes. Inhibitory proteins called I\u03baB bind tightly to the dimers and hold them in an inactive state within the cytoplasm of unstimulated cells. There are three major I\u03baB proteins in mammals (I\u03baB \u03b1, \u03b2, and \u03b5), and the signals that release NF\u03baB dimers do so by triggering a signaling pathway that leads to the phosphorylation, ubiquitylation, and consequent degradation of the I\u03baB proteins (Figure 15\u201362)."
        },
        {
            "id": "Pharmacology_Katzung_5378",
            "title": "Pharmacology_Katzung",
            "content": "All NRTIs may be associated with mitochondrial toxicity, which may manifest as peripheral neuropathy, pancreatitis, lipoatrophy, and hepatic steatosis. Less commonly, lactic acidosis may occur, which can be fatal. NRTI treatment should be suspended in the setting of rapidly rising aminotransferase levels, progressive hepatomegaly, or metabolic acidosis of unknown cause. Lipoatrophy and insulin resistance may occur most frequently with use of the thymidine analogs stavudine and zidovudine, and least frequently with use of tenofovir, lamivudine, emtricitabine, and abacavir."
        },
        {
            "id": "Cell_Biology_Alberts_2351",
            "title": "Cell_Biology_Alberts",
            "content": "loss-of-function mutation: either reduces or abolishes the activity of the gene. These are the most common class of mutations. Loss-of-function mutations are usually recessive\u2014the organism can usually function normally as long as it retains at least one normal copy of the affected gene. null mutation: a loss-of-function mutation that completely abolishes the activity of the gene. TWO GENES OR ONE? Given two mutations that produce the same phenotype, how can we tell whether they are mutations in the same gene? If the mutations are recessive (as they most often are), the answer can be found by a complementation test. COMPLEMENTATION: MUTATIONS IN TWO DIFFERENT GENES DELETION: deletes a segment of a chromosome"
        },
        {
            "id": "Pathology_Robbins_1643",
            "title": "Pathology_Robbins",
            "content": "How do premutations cause disease? In these patients, the FMR1 gene instead of being methylated and silenced continues to be transcribed. CGG-containing FMR1 mRNAs so formed are \u201ctoxic.\u201d They accumulate in the nucleus and form intranuclear inclusions. In this process the aggregated mRNA recruits RNA-binding proteins. Fig. 7.18 Amodelfortheactionoffamilialmentalretardationprotein(FMRP)inneurons.FMRPplaysacriticalroleinregulatingthetranslationofaxonalproteinsfromboundRNAs.Theselocallyproducedproteins,inturn,playdiverserolesinthemicroenvironmentofthesynapse.(Adapted from Hin P, Warren ST: New insights into fragile X syndrome: from molecules to neu-robehavior, TrendsBiochemSci28:152, 2003.) FMRP Ribosomes Axonal proteins Dendritic proteins Ribosomes FMRP-mRNA complex AXON DENDRITE http://ebooksmedicine.net Perhaps sequestration of these proteins at abnormal locations leads to events that are toxic to the cell."
        },
        {
            "id": "InternalMed_Harrison_5578",
            "title": "InternalMed_Harrison",
            "content": "ResveratrolRapamycinSpermidineHOOOOOOOOOHOOOHONMetforminNHNHNNH2NHHOOHOHH2NNH2HNFIGURE 94e-5 Chemical structures of four agents (resveratrol, rapamycin, spermidine, and metformin) that have been shown to delay aging in experimental animal models. Rapamycin. Rapamycin, an inhibitor of mTOR, was originally discovered on Easter Island (Rapa Nui; hence its name) as a bacterial secretion with antibiotic properties. Before its immersion in the antiaging field, rapamycin already had a longstanding career as an immunosuppressant and cancer chemotherapeutic in humans. Rapamycin extends lifespan in all organisms tested so far, including yeast, flies, worms, and mice. However, the potential utility of rapamycin for human lifespan extension is likely to be limited by adverse effects related to immunosuppression, wound healing, proteinuria, and hypercholesterolemia, among others. An alternative strategy may be intermittent rapamycin feeding, which was found to increase mouse lifespan."
        },
        {
            "id": "Pathology_Robbins_1257",
            "title": "Pathology_Robbins",
            "content": "It is now accepted that loss of normal cell cycle control is central to malignant transformation and that at least http://ebooksmedicine.net one of the four key regulators of the cell cycle (p16, cyclin D, CDK4, RB) is mutated in most human cancers. Notably, in cancers caused by certain oncogenic viruses (discussed later), this is achieved through direct targeting of RB by viral proteins. For example, the human papillomavirus (HPV) E7 protein binds to the hypophosphorylated form of RB, preventing it from inhibiting the E2F transcription factors. Thus, RB is functionally deleted, leading to uncontrolled growth. Likeothertumorsuppressorgenes,bothcopiesofRB mustbedysfunctionalfortumordevelopmenttooccur. Incasesoffamilialretinoblastoma,onedefectivecopyoftheRB geneispresentinthegermline,sothatonlyoneadditionalsomaticmutationisneededtocompletelyeliminateRBfunction."
        },
        {
            "id": "InternalMed_Harrison_26940",
            "title": "InternalMed_Harrison",
            "content": "import into the mitochondrion; and (3) increases the availability and phosphorylation of CREB (cAMP response element binding), a transcription factor that enhances transcription of CYP11A1 and other enzymes required for glucocorticoid synthesis."
        },
        {
            "id": "Pathology_Robbins_1289",
            "title": "Pathology_Robbins",
            "content": "The flipside of the coin is that tumor suppressors often inhibit metabolic pathways that support growth. We have already discussed the \u201cbraking\u201d effect of the tumor suppressors NF1 and PTEN on signals downstream of growth factor receptors and RAS, allowing them to oppose the Warburg effect. Indeed, it may be that many (and perhaps all) tumor suppressors that induce growth arrest suppress the Warburg effect. For example, p53, arguably the most important tumor suppressor, upregulates target genes that collectively inhibit glucose uptake, glycolysis, lipogenesis, and the generation of NADPH (a key cofactor needed for the biosynthesis of macromolecules). Thus, it is increasingly clear that the functions of many oncoproteins and tumor suppressors are inextricably intertwined with cellular metabolism."
        },
        {
            "id": "InternalMed_Harrison_24845",
            "title": "InternalMed_Harrison",
            "content": "MostpatientscarryaheterozygousmutationinthegeneencodingFas that is characterized by dominant inheritance and variable penetrance, depending on the nature of the mutation. A rare and severe form of the disease with early onset can be observed in patients carrying a biallelic mutationofFas,whichprofoundlyimpairstheprotein\u2019sexpressionand/ or function. Fas-ligand, caspase 10, caspase 8, and neuroblastoma RAS viral oncogene homologue (NRAS) mutations have also been reported in a few cases of ALPS. Many cases of ALPS have not been precisely delineated at the molecular level. A B cell\u2013predominant ALPS has recently been found associated with a protein kinase C\u03b4 gene mutation. Treatment ofALPS isessentially basedon the useof proapoptoticdrugs, which need to be carefully administered in order to avoid toxicity. CoLITIS, AUToIMMUNITY, ANd PRIMARY IMMUNodEFICIENCIES"
        },
        {
            "id": "Physiology_Levy_272",
            "title": "Physiology_Levy",
            "content": "These pathways ensure that the cellular response to external signals is specific, amplified, tightly regulated, and coordinated. 2. There are two classes of GTP-binding proteins: monomeric G proteins and heterotrimeric G proteins composed of \u03b1, \u03b2, and \u03b3 subunits. Monomeric G proteins regulate actin cytoskeleton organization, cell cycle progression, intracellular vesicular transport, and gene expression. Heterotrimeric G proteins regulate ion channels, adenylyl cyclase and the cAMP-PKA signaling pathway, phosphodiesterases (which also regulate cAMP and cGMP signaling pathways), and Cheung E, Kraus WL. Genomic analyses of hormone signaling and gene regulation. Annu Rev Physiol. 2010;72:191-218. Huang P, Chandra V, Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol. 2010;72:247-272. Levin ER. Extranuclear steroid receptors are essential for steroid hormone actions. Annu Rev Med. 2015;66:271-280."
        },
        {
            "id": "InternalMed_Harrison_6161",
            "title": "InternalMed_Harrison",
            "content": "with subsequent degradation of I\u03baB by the proteasome. Inhibition of IKK activity should selectively block the activation of NF-\u03baB target genes, many of which promote cell survival. Inhibitors of proteasome function are Food and Drug Administration approved and may work in part by preventing destruction of I\u03baB, thus blocking NF-\u03baB nuclear localization. NF-\u03baB is unlikely to be the only target for proteasome inhibitors."
        },
        {
            "id": "InternalMed_Harrison_6042",
            "title": "InternalMed_Harrison",
            "content": "The first indication of the existence of tumor-suppressor genes came from experiments showing that fusion of mouse cancer cells with normal mouse fibroblasts led to a nonmalignant phenotype in the fused cells. The normal role of tumor-suppressor genes is to restrain cell growth, and the function of these genes is inactivated in cancer. The two major types of somatic lesions observed in tumor-suppressor genes during tumor development are point mutations and large deletions. Point mutations in the coding region of tumor-suppressor genes will frequently lead to truncated protein products or otherwise nonfunctional proteins. Similarly, deletions lead to the loss of a functional product and sometimes encompass the entire gene or even the entire chromosome arm, leading to loss of heterozygosity (LOH) in the tumor DNA compared to the corresponding normal tissue DNA (Fig. 101e-4). LOH in tumor DNA is considered a hallmark for the presence of a tumor-suppressor gene at a particular chromosomal"
        },
        {
            "id": "Pharmacology_Katzung_5403",
            "title": "Pharmacology_Katzung",
            "content": "Tenofovir disoproxil fumarate is one of the NRTI agents recommended for use in pregnancy (Table 49\u20135). The combination of tenofovir and emtricitabine is recommended as pre-exposure prophylaxis to reduce HIV acquisition in high-risk persons."
        },
        {
            "id": "Physiology_Levy_3764",
            "title": "Physiology_Levy",
            "content": "transducer and activator of transcription proteins [STATs], Mothers against decapentaplegic homologs [Smads]). Steroid hormones have slower, longer term effects that involve chromatin remodeling and changes in gene expression. Increasing evidence indicates that steroid hormones have rapid, nongenomic effects as well, but these pathways are still being elucidated."
        },
        {
            "id": "Pharmacology_Katzung_388",
            "title": "Pharmacology_Katzung",
            "content": "Increased P450 synthesis requires enhanced transcription and translation along with increased synthesis of heme, its prosthetic cofactor. A cytoplasmic receptor (termed AhR) for polycyclic aromatic hydrocarbons (eg, benzo[a]pyrene, dioxin) has been identified. The translocation of the inducer-receptor complex into the nucleus, followed by ligand-induced dimerization with Arnt, a closely related nuclear protein, leads to subsequent activation of regulatory elements of CYP1A genes, resulting in their induction. This is also the mechanism of CYP1A induction by cruciferous vegetables, and the proton pump inhibitor, omeprazole. A pregnane X receptor (PXR), a member of the steroid-retinoidthyroid hormone receptor family, has recently been shown to mediate CYP3A induction by various chemicals (dexamethasone, rifampin, mifepristone, phenobarbital, atorvastatin, and hyperforin, a constituent of St. John\u2019s wort) in the liver and intestinal mucosa. A similar receptor, the constitutive androstane"
        }
    ],
    "scores": [
        0.027228470706731574,
        0.025033068783068782,
        0.01960972796308757,
        0.0196078431372549,
        0.01951637471439452,
        0.019419306184012067,
        0.01879964695498676,
        0.01709090909090909,
        0.0168928470455188,
        0.016207349081364827,
        0.01617933723196881,
        0.015866047911701993,
        0.01508295625942685,
        0.014609545596339816,
        0.013680926916221033,
        0.009900990099009901,
        0.009900990099009901,
        0.00980392156862745,
        0.009708737864077669,
        0.009708737864077669,
        0.009615384615384616,
        0.009615384615384616,
        0.009523809523809525,
        0.009523809523809525,
        0.009433962264150943,
        0.009433962264150943,
        0.009433962264150943,
        0.009433962264150943,
        0.009345794392523364,
        0.009345794392523364,
        0.009345794392523364,
        0.009345794392523364
    ]
}